Differences

This shows you the differences between two versions of the page.

--- pharmaceutical_companies:ophirex [2022/04/16 10:06]
liam [Antivenom]
+++ pharmaceutical_companies:ophirex [2024/11/11 18:28] (current)
liam [External links]
@@ Line 9: / Line 9: @@
 [[Derrick Rossi]], co-founder of [[pharmaceutical_companies:Moderna]], is an advisor to Ophirex.((Farooqui, S. (2021, July 6). //Moderna co-founder using mRNA technology to treat venomous snakebites.// Global News. https://archive.ph/URhV7))
+==== Funding ====
+Ophirex is funded by multiple awards from the [[:US Department of Defense]], a grant from [[:Wellcome Trust]], and the [[:World Health Organization]].((Rao, S. (2020, March 2). //Ophirex receives Wellcome Trust award to advance clinical development of novel snakebite treatment.// Business Wire. https://archive.ph/LHsYv)) ((Karon, P. (2020). //Snakebites are a deadly threat worldwide. Who’s behind the push for a new treatment?// Inside Philanthropy. https://web.archive.org/web/20220413132035/https://static1.squarespace.com/static/5eb10eb62bf19e1bbec031bc/t/60c38b9ca1a11d3f55c2fb7d/1623427997415/Inside+Philanthropy+2020-12-17+Snakebites.pdf)) ((//Broad Spectrum Envenomation Treatment.// SBIR. Retrieved April 16, 2022, from https://archive.ph/T9toA))
 ==== Staff ====
@@ Line 35: / Line 38: @@
 {{:pharmaceutical_companies:ophirex_bravo_trial_spot.jpeg?150 |}}
-Ophirex is running a clinical trial titled "Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite (BRAVO)" in collaboration with [[Premier Research International]].((Ophirex, Inc., & Premier Research International LLC. (2022, February 9). //Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi-Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes.// ClinicalTrials.gov. https://archive.ph/xNuHy))
+Ophirex is running a clinical trial titled "Broad-spectrum Rapid Antidote: Varespladib Oral for Snakebite (BRAVO)" in collaboration with [[:Premier Research International]].((Ophirex, Inc., & Premier Research International LLC. (2022, February 9). //Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Efficacy of a Multi-Dose Regimen of Oral Varespladib-Methyl in Subjects Bitten by Venomous Snakes.// ClinicalTrials.gov. https://archive.ph/xNuHy))
+===== External links =====
+  * [[https://wiki.whiteroseintelligence.com/en/Ophirex|White Rose Wiki]]